abstract
This study compared taurine, aminomethanesulfonic acid, homotaurine and hypotaurine for the ability to modify indices of oxidative stress and membrane damage associated with type 2 diabetes. In the study, male Goto-Kakizaki and Wistar-Kyoto rats were allowed free access to a high fat and normal diet, respectively, for 9 weeks. At the end of week 8, half of the animals in each group received a daily intraperitoneal dose of a sulfur compound (0.612 M/kg) for 5 days and, 24 hr after the last treatment, blood samples were withdrawn by cardiac puncture to obtain plasma and erythrocyte fractions for biochemical analyses. Relative to control values, taurine and its congeners reduced membrane damage, the formation of intracellular malondialdehyde and oxidized glutathione, and the decreases in reduced glutathione and antioxidative enzyme activities in diabetic erythrocytes. Except for a few isolated instances, all test compounds were equiprotective.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aebi H (1984) Catalase in vitro. Methods Enzymol 105:121–126
Aruoma OI, Halliwell B, Hoey BM, Butler J (1988) The antioxidant action of taurine, hypotaurine and their metabolic precursors Biochem J 256:251–255
Baynes JW, Thorpe SR (1999) Role of oxidative stress in diabetic complications. A new perspective on an old paradigm. Diabetes 48:1–9
Beard KM, Shangari N, Wu B, O’Brien PJ (2003) Metabolism, not autoxidation plays a role in α-oxoaldehyde- and reducing sugar-induced erythrocyte GSH depletion: relevance for diabetes mellitus. Mol Cell Biochem 252:331–338
Buege JA, Aust SD (1978) Microsomal lipid peroxidation. Methods Enzymol 52:302–310
Ceriello A (2003) New insights on oxidative stress and diabetic complications may lead to a “causal” antioxidant therapy. Diabetes Care 26:1589–1596
Da Ros R, Assaloni R, Ceriello A (2004) Antioxidant therapy in diabetic complications:what is new? Curr Vasc Pharmacol 2:335–341
Donma O, Yorulmaz E, Pekel H, Suyugul N (2002) Blood and lens lipid peroxidation and antioxidant status in normal individuals, senile and diabetic cataractous patients. Curr Eye Res 25:9–16
Djordjevic A, Spasic S, Jovanovic-Galovic A, Djordjevic R, Grubor-Lajsic G (2004) Oxidative stress in diabetic pregnancy: SOD, CAT and GSH-Px activity and lipid peroxidation. J Matern Fetal Neonatal Med 16:367–372
Evans JL (2007) Antioxidants: do they have a role in the treatment of insulin resistance? Indian J Med Res 125:355–372
Fellman JH, Roth ES (1985) The biological oxidation of hypotaurine to taurine: hypotaurine as an antioxidant. In: Oja SS, Ahtee L, Kontro P, Paasonen MK (eds) Taurine: biological actions and clinical perspectives, Alan R. Liss, New York, pp 71–82
Flohé L, Günzler WA (1984) Assays of glutathione peroxidase. Methods Enzymol 105:114–121
Gallou G, Ruelland A, Campion L, Maugendre D, Le Moullec N, Legras B, Allannic H, Cloarec L (1994) Increase in thiobarbituric acid-reactive substances and vascular complications in type 2 diabetes mellitus Diabetes Metab 20:258–264
Goodman HO, Shihabi ZK (1990) Supplemental taurine in diabetic rats: effects on plasma glucose and triglycerides. Biochem Med Metab Biol 43:1–9
Gürler B, Vural H, Yilmaz N, Oguz H, Satici A, Aksoy N (2000) The role of oxidative stress in diabetic retinopathy. Eye 14 (Pt 5):730–735
Hissin PJ, Hilf R (1976) A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem 74:214–226
Huxtable RJ, Sebring LA (1986) Towards a unifying theory for the actions of taurine. Trends Pharmacol Sci 7:481–485
Huxtable RJ (1992) Physiological actions of taurine. Pharmacol Rev 72:101–163
Kaneto H, Nakatani Y, Kawamori D, Miyatsuka T, Matsuoka T (2004) Involvement of oxidative stress and the JNK pathway in glucose toxicity. Rev Diabet Stud 1:165–174
Kesavulu MM, Giri R, Kameswara R.B, Apparao C (2000) Lipid peroxidation and antioxidant enzyme levels in type 2 diabetics with microvascular complications. Diabetes Metab 26:387–392
Kulakowski EC, Maturo J (1984) Hypoglycemic properties of taurine: not mediated by enhanced insulin release. Biochem Pharmacol 33:2835–2838
Maiese K, Morhan SD, Chong ZZ (2007) Oxidative stress biology and cell injury during type 1 and type 2 diabetes mellitus. Curr Neurovasc Res 4:63–71
Memisogullari R, Taysi S, Bakan E, Capoglu I (2003) Antioxidant status and lipid peroxidation in type II diabetes mellitus. Cell Biochem Funct 21:291–296
Misra HP, Fridovich I (1972) The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 247:3170–3175
Ogasawara M, Nakamura T, Koyama I, Nemoto M, Yoshida T (1994) Reactivity of taurine with aldehydes and its physiological role. In: Huxtable R, Michalk DV (eds) Taurine in health and disease, Plenum Press, New York, pp 71–78
Pitari G,Dupre S, Sprinto A, Antoni G (2000) Hypotaurine protection on cell damage by singlet oxygen. In: Della Corte L, Huxtable RJ, Sgaragli G, Tipton KF (eds) Taurine 4: taurine and excitable tissues, Kluwer Academic/Plenum Publishers, New York, pp 157–162
Pokhrel KP, Lau-Cam C.A (2000) In vitro and in vivo effects of taurine and structurally related sulfur-containing compounds against phenylhydrazine-induced oxidative damage to erythrocytes. In: Della Corte L, Huxtable RJ, Sgaragli G, Tipton KF (eds) Taurine 4: taurine and excitable tissues, Kluwer Academic/Plenum Publishers, New York, pp 503–522
Schaffer SW, Azuma J (1992) Myocardial physiological effects of taurine and their significance. In: Lombardini JB, Schaffer SW, Azuma J (eds) Taurine: nutritional value and mechanisms of action, Plenum Press, New York, pp 105–120
Tadolini B, Pintus G, Pinna GG, Bennardini F, Franconi F (1995) Effects of taurine and hypotaurine on lipid peroxidation. Biochem Biophys Res Commun 213:820–826
Tas S, Sarandol, E, Ayvalik SZ, Serdar Z, Dirican M (2007) Vanadyl sulfate, taurine, and combined vanadyl sulfate and taurine treatments in diabetic rats: effects on the oxidative and antioxidative systems. Arch Med Res 38:276–283
Trachtman H, Futterweit D, Maesaka J, Ma C, Valderrama E, Fuchs A, Tarectecan AA, Rao PS, Sturman JA, Boles TH et al. (1995) Taurine ameliorates chronic streptozocin-induced diabetic nephropathy in rats Am J Physiol 269:F429–F438
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this paper
Cite this paper
Gossai, D., Lau-Cam, C.A. (2009). The Effects of Taurine, Taurine Homologs and Hypotaurine on Cell and Membrane Antioxidative System Alterations Caused by Type 2 Diabetes in Rat Erythrocytes. In: Azuma, J., Schaffer, S.W., Ito, T. (eds) Taurine 7. Advances in Experimental Medicine and Biology, vol 643. Springer, New York, NY. https://doi.org/10.1007/978-0-387-75681-3_37
Download citation
DOI: https://doi.org/10.1007/978-0-387-75681-3_37
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-75680-6
Online ISBN: 978-0-387-75681-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)